Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukhdeep Bhogal

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|June 27, 2019
Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized TrialsSukhdeep Bhogal, Debabrata Mukherjee, Jayant Bagai, et al.
International Journal of Cardiology|July 21, 2023
Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacementSukhdeep Bhogal, Toby Rogers, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 2, 2023
Impact of IVUS and OCT on physician decision-making during post-PCI optimizationSukhdeep Bhogal, Hayder Hashim, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 8, 2024
Markedly elevated high-sensitivity troponin and in-hospital mortality after cardiac surgeryPavan Reddy, Matteo Cellamare, Ilan Merdler, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2023
Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVRIlan Merdler, Brian Case, Sukhdeep Bhogal, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2023
Gender disparities related to clinical characteristics and outcomes of patients undergoing transseptal proceduresAmer I Aladin, Tareq Arar, Fnu Lubaina, et al.
Progress in Cardiovascular Diseases|March 30, 2019
Diabetic cardiomyopathy - A comprehensive updated reviewGhulam Murtaza, Hafeez Ul Hassan Virk, Muhammad Khalid, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicityKalyan R Chitturi, Sukhdeep Bhogal, Seyed Ebrahim Kassaian, et al.
Journal of the American College of Cardiology|November 17, 2022
Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art ReviewMohit Pahuja, Adam Johnson, Ryan Kabir, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Cardiovascular & Hematological Disorders Drug Targets|June 27, 2019
Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized TrialsSukhdeep Bhogal, Debabrata Mukherjee, Jayant Bagai, et al.
International Journal of Cardiology|July 21, 2023
Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacementSukhdeep Bhogal, Toby Rogers, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 2, 2023
Impact of IVUS and OCT on physician decision-making during post-PCI optimizationSukhdeep Bhogal, Hayder Hashim, Ilan Merdler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 8, 2024
Markedly elevated high-sensitivity troponin and in-hospital mortality after cardiac surgeryPavan Reddy, Matteo Cellamare, Ilan Merdler, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2023
Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVRIlan Merdler, Brian Case, Sukhdeep Bhogal, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2023
Gender disparities related to clinical characteristics and outcomes of patients undergoing transseptal proceduresAmer I Aladin, Tareq Arar, Fnu Lubaina, et al.
Progress in Cardiovascular Diseases|March 30, 2019
Diabetic cardiomyopathy - A comprehensive updated reviewGhulam Murtaza, Hafeez Ul Hassan Virk, Muhammad Khalid, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicityKalyan R Chitturi, Sukhdeep Bhogal, Seyed Ebrahim Kassaian, et al.
Journal of the American College of Cardiology|November 17, 2022
Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art ReviewMohit Pahuja, Adam Johnson, Ryan Kabir, et al.
Pageof 5